In the final installment of his interview with Pharmaceutical Commerce, Cencora's Gregg Gorniak looks back at DSCSA's ...
As pharmaceutical companies move AI into patient access and support operations, most still rely on manual sampling and ...
As hub transitions accelerate and digital tools reshape how support is delivered, four patient services experts weigh in on what's driving change in 2026, and what manufacturers need to get right to ...
Geopolitical instability is pushing life sciences firms to map supply chains beyond suppliers to protect trials and patient access.
Shawn Seamans, Chief Commercial Officer, CoverMyMeds | Authors | Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking ...
Ben Sharples, LogiPharma event director, examines how life sciences organizations are adapting to AI in the supply chain, with expert testimony from LogiPharma partners.
Logan Melchione shares how ClaimGuardRx gives account teams a fast, conversational way to tackle diversion and fraud together, and what that means for clients and patients.
HDA's Kala Shankle unpacks the biggest open question on preemption and offers a two-step playbook for wholesalers and 3PLs ...
In this week's Pharma Pulse, DHL breaks ground on a new cold chain hub at Singapore's Changi Airport, a new report finds ...
Recognize the role human factors expertise, onboarding, and training and education play in building patient confidence and supporting long-term adherence. Joe Reynolds, Head of User Experience ...
Newly added signatories include Alcon, Astellas, BeOne, BridgeBio, CSL, Kyowa Kirin, Sun, Teva, and UCB, spanning hemophilia, ...
Pharmacy directors are using the growing number of publicly visible drug prices as leverage, new research shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results